Basics MIMEDX GROUP INC MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. IPO Date: March 1, 2008 Sector: Healthcare Industry: Biotech Market Cap: $1.06B Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 2.48% Avg Daily Range (30 D): $0.09 | 1.34% Avg Daily Range (90 D): $0.12 | 1.76% Institutional Daily Volume Avg Daily Volume: .76M Avg Daily Volume (30 D): .53M Avg Daily Volume (90 D): .59M Trade Size Avg Trade Size (Sh.): 146 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 83 Institutional Trades Total Inst.Trades: 1,983 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $.85M Avg Inst. Trade (90 D): $.97M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.51M Avg Closing Trade (30 D): $.86M Avg Closing Trade (90 D): $.93M Avg Closing Volume: 178.26K     News Sep 3, 2025 @ 12:00 PM MIMEDX to Sponsor and Attend Symposium on Advanced... Source: Matt Notarianni Feb 12, 2025 @ 12:00 PM MediWound Initiates the VALUE Global Phase III Piv... Source: N/A Nov 26, 2024 @ 11:47 AM Chronic Wound Care Market to Expand at a Modest 4.... Source: Globe Newswire Oct 8, 2024 @ 8:01 PM MIMEDX Points to The New York Times Article on the... Source: N/A Oct 1, 2024 @ 8:01 PM MIMEDX Showcases Leading Allograft Portfolio and I... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $.07 $.05 $.05 Diluted EPS $.06 $.05 $.05 Revenue $ 98.61M $ 88.21M $ 92.91M Gross Profit $ 79.92M $ 71.65M $ 76M Net Income / Loss $ 9.62M $ 7.02M $ 7.44M Operating Income / Loss $ 12.37M $ 8.25M $ 11.05M Cost of Revenue $ 18.68M $ 16.56M $ 16.91M Net Cash Flow $ 12.44M $ 2.02M $ 15.62M PE Ratio 118.67     Splits Apr 02, 2008:   11:34